The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Vasopressinergic Regulation of the Hypothalamic Pituitary Adrenal Axis and Stress Adaptation
Open accessAbstract
Vasopressin (VP) stimulates pituitary ACTH secretion through interaction with receptors of the V1b subtype (V1bR, V3R), located in the plasma membrane of the pituitary corticotroph, mainly by potentiating the stimulatory effects of corticotropin releasing hormone (CRH). Chronic stress paradigms associated with corticotroph hyperresponsiveness lead to preferential expression of hypothalamic VP over CRH and upregulation of pituitary V1bR, suggesting an important role for VP during adaptation of the hypothalamic-pituitary-adrenal (HPA) axis to stress. Vasopressinergic regulation of ACTH secretion depends on the number of V1bRs as well as coupling of the receptor to phospholipase C (PLC) in the pituitary. Regulation of V1bR gene transcription may involve a number of regulatory elements in the promoter region, of which a GAGA box was shown to be essential. Although V1bR gene transcription is necessary to maintain V1bR mRNA levels, the lack of correlation between VP binding and V1bR mRNA suggests that regulation of mRNA translation is a major regulatory step of the number of V1bRs. V1bR translation appears to be under tonic inhibition by upstream minicistrons and positive regulation through protein kinase C (PKC) activation of an internal ribosome entry site (IRES) in the 5' untranslated region (5'UTR) of the mRNA. The data provide mechanisms by which regulation of hypothalamic VP and pituitary V1bR content contribute to controlling HPA axis activity during chronic stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In essence, CRH and AVP are both required as stimulatory inputs to corticotrope cells for a complete ACTH response in physiologically normal as well as in various stressful conditions (32, 38, 48–51).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgan, J., & Curran, T. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002225 · Cited by 2,689 · cited 3×
“…leading to the production of intermediate early genes or transcription factors capable to interact with glucocorticoid receptors and to modify their activity at the responsive element in the gene promoter (Diamond et al., 1990; Morgan and Curran, 1991; Webster and Cidlowski, 1999).”
BackgroundNeurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 1×
“Glucocorticoids are likely to act at multiple sites, inhibiting VP secretion by direct actions on the parvocellular neuron, and indirectly by modifying the activity of neural pathways to the parvocellular neuron such as GABAergic and glutamatergic afferents (Herman and Cullinan, 1997; Kiss, 1998).”
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.887 · Cited by 1,631 · cited 1×
“Upstream ORFs have been described in yeast and several eukaryotic mRNAs and are recognized to reduce the ability of ribosomes to linearly scan the V1b 50UTR mRNA according to conventional scanning models and therefore to slow translation (Kozak, 1991).”
BackgroundDiamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,274 · cited 2×
“…leading to the production of intermediate early genes or transcription factors capable to interact with glucocorticoid receptors and to modify their activity at the responsive element in the gene promoter (Diamond et al., 1990; Morgan and Curran, 1991; Webster and Cidlowski, 1999).”
BackgroundCorticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · cited 2×
“In humans and rodents, VP alone is a weak stimulus of ACTH secretion, but through its interaction with CRH it contributes to maintaining corticotroph responsiveness in spite of elevated glucocorticoid levels during chronic stress (Gilles et al., 1982; Antoni, 1993; Aguilera, 1994).”
BackgroundDi, S., Malcher‐Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 820 · cited 1×
“Recent studies show that glucocorticoids induce the release of endogenous cannabinoids in the PVN, which can mediate rapid indirect, non-genomic glucocorticoid feedback in the parvocellular neuron (Di et al., 2003).”
BackgroundRegulation of ACTH Secretion: Variations on a Theme of B
DALLMAN, M. F., AKANA, S. F., CASCIO, C. S., DARLINGTON, D. N., JACOBSON, L., & LEVIN, N. (1987) · Proceedings of the 1986 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571143-2.50010-1 · Cited by 655 · cited 3×
“Circulating glucocorticoids exert a negative feedback effect on the expression of CRH and VP in parvocellular PVN neurons (Dallman et al., 1987), but there is evidence of preferential inhibition of VP compared with CRH expression (Ma et al.”
BackgroundVasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636 · cited 4×
“external zone of the median eminence (Antoni, 1993).”
BackgroundInfluentialRegulation of pituitary ACTH secretion during chronic stress
Aguilera, G. (1994) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1994.1013 · Cited by 557 · cited 11×
“Also, VP markedly potentiates the stimulatory effects of corticotropin releasing hormone (CRH) on ACTH secretion (Gilles et al., 1982; DeGoeij et al., 1991; Aguilera, 1994).”
BackgroundInfluentialHormonal regulation of peptide receptors and target cell responses
Catt, K. J., Harwood, J. P., Aguilera, G., & Dufau, M. L. (1979) · Nature · doi:10.1038/280109a0 · Cited by 531 · cited 1×
“In addition to receptor synthesis, the number of active VP receptors could be influenced by ligand binding, leading to receptor desensitization and internalization as occurs with other G-protein coupled receptors (Catt et al., 1979; Ferguson and Caron, 1998).”
Background
Research works printed but not linked: 10
- Carvallo P., 1989, Endocrinol, 3, 1935
- Dallman M.F., 1987, Recent Prog. Horm. Res., 42, 113
- DeGoeij D.C.E., 1991, Neuroendocrinology, 53, 150, 10.1159/000125712 · DOI · Paper page
- Levin N., 1991, Front. Neuroendocrinol., 12, 1
- McCann S.M., 1954, Proc. Natl Acad. Sci. USA, 87, 318
- Mori Y., 1996, Role of upstream AUG triplets, Hypertension, 28, 810
- Rabadan-Diehl C., 2002, Neuroscience, Orlando FL, abst
- Rabadan-Diehl C., 2003, Endocrinol, 17, 1959
- Seibold A., 1992, Am. J. Hum. Genet., 51, 1078
- Sonnenberg, N. (1996) In: Hershey, J.W.B., Mathews, M.B. and Sonenberg, N., eds, Translational Control (Cold Spring Harbor Lab. Press, Plainview, NY), pp 245–269.
Cited by
Sorted by citations
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
“As such, VP is part of the hypothalamic-pituitaryadrenal (HPA) axis, a system involved in the neuroendocrine stress response (Herman, 1995; Volpi et al., 2004).”
BackgroundRole of glucocorticoid negative feedback in the regulation of HPA axis pulsatility
Gjerstad, J. K., Lightman, S. L., & Spiga, F. (2018) · Stress · doi:10.1080/10253890.2018.1470238 · Cited by 437
“Although the role of vasopressin in regulating ACTH secretion in responses to stress is well known (Volpi et al., 2004), current evidence suggests that vasopressin does not regulate basal HPA axis activity.”
BackgroundYoung, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222
“…the role of the Avpr1b in regulating adrenocorticotropin hormone from the anterior pituitary in response to stress, especially chronic, has been extensively studied (for reviews, see (Engelmann et al., 2004; Volpi et al., 2004)) ever since the receptor was first described (Antoni et al., 1984).”
BackgroundResultEpigenetics of stress adaptations in the brain
Stankiewicz, A. M., Swiergiel, A. H., & Lisowski, P. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.07.003 · Cited by 220
The stress hormone copeptin: a new prognostic biomarker in acute illness
Christ‐Crain, M. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13101 · Cited by 216
Landgraf, R., Kessler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 201
Brown, C. H., Bains, J. S., Ludwig, M., & Stern, J. E. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12051 · Cited by 179
Brain and peripheral angiotensin II play a major role in stress
Saavedra, J. M., & Benický, J. (2007) · Stress · doi:10.1080/10253890701350735 · Cited by 166
“Brain Ang II also stimulates vasopressin (AVP) formation in the PVN and its release from the median eminence (Saavedra 1992) to participate with CRF in enhancing ACTH production (Antoni 1993; Volpi et al. 2004).”
BackgroundSaleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161
Aguilera, G., Subburaju, S., YOUNG, S., & CHEN, J. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00403-2 · Cited by 151
Lolait, S. J., Stewart, L. Q., Jessop, D. S., Young, W. S., & O’Carroll, A. (2006) · Endocrinology · doi:10.1210/en.2006-1309 · Cited by 149
“hypothalamic-pituitary-adrenal (HPA) axis (6, 7).”
Exploring the role of neuropeptides in depression and anxiety
Rana, T., Behl, T., Sehgal, A., Singh, S., Sharma, N., Abdeen, A., Ibrahim, S. F., Mani, V., Iqbal, M. S., Bhatia, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110478 · Cited by 128
The vasopressin Avpr1b receptor: Molecular and pharmacological studies
Roper, J. A., O'Carroll, A.-M., Young, W. S., & Lolait, S. (2010) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 122
“…Avp and pituitary Avpr1b responsiveness is maintained during stress adaptation suggests the existence of numerous transcriptional and translational regulatory components involved in PVN and pituitary plasticity that dynamically alter Avp and Avpr1b levels according to demand (Volpi et al. 2004a,b).”
BackgroundOxytocin and vasopressin: genetics and behavioral implications
Caldwell, H. K., & Young, W. S. (2006) · Handbook of Neurochemistry and Molecular Neurobiology · doi:10.1007/978-0-387-30381-9_25 · Cited by 113
Rationally designed peptide regulators of protein kinase C
Churchill, E. N., Qvit, N., & Mochly‐Rosen, D. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.002 · Cited by 105
Ellis, B. J., Horn, A. J., Carter, C. S., van IJzendoorn, M. H., & Bakermans‐Kranenburg, M. J. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101985 · Cited by 103
Goncharova, N. D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00026 · Cited by 102
“Nevertheless, AVP is still considered as an important regulator of the HPA axis (Antoni, 1993; Herman, 1995; Volpi et al., 2004; Aguilera, 2011).”
BackgroundChronic Stress and Individual Vulnerability
Schmidt, M. V., Sterlemann, V., & Müller, M. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.017 · Cited by 104
Desbonnet, L., Garrett, L., Daly, E., McDermott, K. W. G., & Dinan, T. G. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.02.004 · Cited by 98
Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats
Mlynarik, M., Zelena, D., Bagdy, G., Makara, G. B., & Ježová, D. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.12.007 · Cited by 94
Litvin, Y., Murakami, G., & Pfaff, D. W. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.007 · Cited by 93
“AVP secreted from parvocellular neurons of the paraventricular nucleus of the hypothalamus (PVN) travels to the anterior pituitary, where it binds V1bRs to both directly control corticotropin release and to exacerbate the effects of corticotropinreleasing factor (CRF) on pituitary corticotrophs [21].”
InfluentialArmando, I., Volpi, S., Aguilera, G., & Saavedra, J. M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.037 · Cited by 86
“Ang II also stimulates vasopressin (AVP) formation in the PVN and its release from the median eminence to participate with CRF in enhancing ACTH production (Volpi et al., 2004; Antoni 1993).”
BackgroundSchmidt, M. V., Sterlemann, V., Wagner, K. V., Niederleitner, B., Ganea, K., Liebl, C., Deussing, J. M., Berger, S., Schütz, G., Holsboer, F., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1211 · Cited by 83
“This is intriguing because chronic stress or high glucocorticoid levels in adults also result in a shift from CRH to AVP in regulating HPA axis activity (42).”
BackgroundPatchev, V. K., & Patchev, A. V. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/vpatchev · Cited by 80
“Extensive research in the past has shown that stress-associated changes in CRH and AVP expression in the PVN follow distinct temporal patterns, with AVP “coming into action” with certain delay or in the course of chronic stress load.(35) Oxytocin and angiotensin also deserve mention as auxiliary peptidergic ACTH secre…”
BackgroundCopeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Mu, D., Cheng, J. H., Qiu, L., & Cheng, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.901990 · Cited by 70
“Another stimulated hypothalamic hormone is AVP, which can interact with CRH and lead to the secretion of ACTH (211).”
BackgroundInfluentialMechanisms of rhythmogenesis: insights from hypothalamic vasopressin neurons
Brown, C. H., & Bourque, C. W. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.11.005 · Cited by 66
Vasopressin, Central Autonomic Control and Blood Pressure Regulation
Lozić, M., Šarenac, O., Murphy, D., & Japundžić‐Žigon, N. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0811-0 · Cited by 67
Magnocellular Neurons and Posterior Pituitary Function
Brown, C. H. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150053 · Cited by 79
“V 1b -receptor activation activates phospholipase C (PLC) in anterior pituitary corticotropes to increase adrenocorticotropic hormone secretion (518).”
Williamson, M., Bingham, B., & Viau, V. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.009 · Cited by 58
Overstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 58
“Evidence indicates that AVP may exist not only in the hypothalamus, where it participates in the hypothalamic–pituitary–adrenal axis (Engelmann et al., 2004; Volpi et al., 2004), but also in other key brain regions such as the medial amygdala (DeVries and Buijs, 1983).”
BackgroundVasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Japundzic-Zigon, N., Lozic, M., Šarenac, O., & Murphy, D. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190717150501 · Cited by 43
Pathogenic involvement of neuropeptides in anxiety and depression
Alldredge, B. (2010) · Neuropeptides · doi:10.1016/j.npep.2009.12.014 · Cited by 56
Sex differences in activation of the hypothalamic–pituitary–adrenal axis by methamphetamine
Zuloaga, D. G., Johnson, L. A., Agam, M. R., & Raber, J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12651 · Cited by 54
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Simon, N. G., Guillon, C., Fabio, K. M., Heindel, N. D., Lu, S., Miller, M., Ferris, C. F., Brownstein, M., Garippa, C., & KOPPEL, G. A. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488908784534586 · Cited by 52
de Winter, R. F. P., Wolterbeek, R., Spinhoven, P., Zitman, F. G., & Goekoop, J. G. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.04.002 · Cited by 50
The Role of Neuropeptides in Suicidal Behavior: A Systematic Review
Serafini, G., Pompili, M., Lindqvist, D., Dwivedi, Y. K., & Girardi, P. (2013) · BioMed Research International · doi:10.1155/2013/687575 · Cited by 49
“Corticotropin-Releasing Factor (CRF), Oxytocin, andArginine Vasopressin (AVP).”
InfluentialBrain vasopressin signaling modulates aspects of maternal behavior in lactating rats
Bayerl, D. S., & Bosch, O. J. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12517 · Cited by 46
Plasma copeptin and long-term outcomes in acute ischemic stroke
Zhang, J.-L., Yin, C., Zhang, Y., Zhao, L., Fu, H.-J., & Feng, J.-C. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12132 · Cited by 46
Lolait, S. J., Stewart, L. Q., Roper, J. A., Harrison, G., Jessop, D., Young, W. S., & O’Carroll, A. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01560.x · Cited by 43
Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage
Fung, C., Marchis, G. M. D., Mira, K., Seiler, M., Arnold, M., Gralla, J., Raabe, A., & Beck, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053191 · Cited by 42
“Vasopressin potentiates the action of corticotrophin releasing hormone and leads downstream to a release of adrenocorticotropic hormone (ACTH) and production of cortisol [8].”
BackgroundSomatodendritic dynorphin release: orchestrating activity patterns of vasopressin neurons
Brown, C. H., Scott, V. M., Ludwig, M., Leng, G., & Bourque, C. W. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351236 · Cited by 41
Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone
McGowan, B. M., MINNION, J. S., Murphy, K. G., Roy, D., Stanley, S. A., Dhillo, W. S., Gardiner, J., Ghatei, M. A., & Bloom, S. R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0603 · Cited by 41
“CRH stimulates adrenocorticotrophic hormone (ACTH) release from the anterior pituitary, an effect that is potentiated by http://joe.endocrinology-journals.org 2014 Society for Endocrinology DOI: 10.1530/JOE-13-0603 Printed in Great Britain AVP (Volpi et al. 2004).”
BackgroundInfluentialThe association of antidiuretic hormone levels with an attack of Meniere's disease
Aoki, M., Ando, K., Kuze, B., Mizuta, K., Hayashi, T., & Ito, Y. (2005) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2005.01107.x · Cited by 39
The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors
Caldwell, H. K., Stewart, J., Wiedholz, L. M., Millstein, R. A., Iacangelo, A. L., Holmes, A., Young, W. S., & Wersinger, S. R. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.001 · Cited by 40
Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke
Mira, K., & Elkind, M. S. V. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.200 · Cited by 37
Social dominance in male vasopressin 1b receptor knockout mice
Caldwell, H. K., Dike, O. E., Stevenson, E. L., Storck, K. E., & Young, W. S. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.03.008 · Cited by 37
“As the Avpr1b gene is important in regulation of the hypothalamic-pituitary-adrenal axis, as it is highly expressed in the anterior pituitary and synergizes the Avp signal with the corticotropinreleasing hormone (Crh) signal to stimulate adrenocorticotropic hormone (ACTH) release (Antoni, 1993), it would be easy to sp…”
BackgroundWei, B., Tai, F., Liu, X., Ma, L., Yang, X., Jia, R., & Zhang, X. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.02.005 · Cited by 33
Zhao, D., & Hong-bin, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023362 · Cited by 31
“It is well known that the activation of hypothalamic-pituitary-adrenocortical (HPA) axis by stress is an important regulatory mechanism used by most mammals to maintain homeostasis after multiple types of challenges. Whether the activation of OT- and AVP-containing neurons in the PVN and SON in response to the RWIS is…”
BackgroundCorbani, M., Marir, R., Trueba, M., Chafaï, M., Vincent, A., Borie, A. M., Desarménien, M. G., Ueta, Y., Corbani, M., Olma, A., et al. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.10.011 · Cited by 33
“…that analogue 3 decoration observed on brain slices corresponded to in vivo rV1B receptor labelling, we performed control experiments on rat corticotroph cells in primary culture known to express high amounts of this vasopressin receptor subtype (Aguilera et al, 2003; Volpi et al, 2004).”
BackgroundMethodBao, L.-L., Jiang, W.-Q., Sun, F.-J., Wang, D., Pan, Y.-J., Song, Z., Wang, C., & Yang, J. (2014) · Neuropeptides · doi:10.1016/j.npep.2014.09.006 · Cited by 31
Magnocellular hypothalamic system and its interaction with the hypothalamo-pituitary-adrenal axis
Sivukhina, E. V., & Jirikowski, G. F. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.008 · Cited by 29
Calvez, J., Lenglos, C., de Ávila, C., Guèvremont, G., & Timofeeva, E. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12236 · Cited by 31
Neurobiological aspects of pain in the context of alcohol use disorder
Cucinello‐Ragland, J. A., & Edwards, S. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.001 · Cited by 27
Scott, V. M., & Brown, C. H. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01961.x · Cited by 27
Danan, D., Todder, D., Zohar, J., & Cohen, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116050 · Cited by 26
Nakamura, K., Fujiwara, Y., Mizutani, R., Sanbe, A., Miyauchi, N., Hiroyama, M., Yamauchi, J., Yamashita, T., Nakamura, S., Mori, T., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1528 · Cited by 25
Multi-factorial somato-dendritic regulation of phasic spike discharge in vasopressin neurons
Brown, C. H., RUAN, M., Scott, V. M., Tobin, V. A., & LUDWIG, M. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00419-6 · Cited by 25
Selvam, R., Jurkevich, A., Kang, S. W., Mikhailova, M. V., Cornett, L. E., & Kuenzel, W. J. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02370.x · Cited by 25
Fabio, K. M., Guillon, C., Lacey, C. J., Lu, S., Heindel, N. D., Ferris, C. F., Placzek, M. S., Jones, G. B., Brownstein, M., & Simon, N. G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.013 · Cited by 24
Examining the Role of Vasopressin in the Modulation of Parental and Sexual Behaviors
Zimmermann-Peruzatto, J. M., Lazzari, V. M., de Moura, A. C., Almeida, S., & Giovenardi, M. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00130 · Cited by 23
Charles, R., Sakurai, T., Takahashi, N., Elder, G. A., Sosa, M. A. G., Young, L. J., & Buxbaum, J. D. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017053 · Cited by 25
“In addition, vasopressin has been shown to be elevated in individuals with major depression and has also been identified as a primary regulator of hypothalamic-pituitary-adrenal axis (HPA) function during chronic psychological stress (Simon et al., 2008; van Londen et al., 1997; Volpi et al., 2004).”
BackgroundFernandes, A. C. A., de Oliveira, F. P., Fernández, G., Vieira, L. D. G., Rosa, C. G., do Nascimento, T., França, S. D. C., Donato, J., Vella, K. R., Antunes‐Rodrigues, J., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00853-z · Cited by 22
Disorders of the Endocrine System
Reed, S. M., Bayly, W. M., & Sellon, D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44329-6.00016-4 · Cited by 25
Jurkevich, A., Berghman, L. R., Cornett, L. E., & Kuenzel, W. J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0636-2 · Cited by 21
“The V1b receptor is expressed in corticotropes mediating the vasopressinergic regulation of ACTH release (Hernando et al. 2001; Volpi et al. 2004).”
BackgroundThe prognostic value of copeptin for acute intracerebral hemorrhage patients
Zhang, A., Li, J., Li, X., Song, L., & Li, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.804 · Cited by 19
“Currently, it is considered that cerebral hemorrhage-related hematoma formation (4,5), increased bleeding and persistent hypertension are associated with early neurological degeneration and poor prognosis (6).”
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 20
“Compared with CRH, vasopressin itself has a weak ability of upregulating the ACTH secretion; however, it markedly potentiates the effect of CRH (Gilles et al. 1982; DeBold et al. 1984; Volpi et al. 2004).”
Stressed-Out Insects: Hormonal Actions and Behavioral Modifications
Johnson, E. C., & White, M. P. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00031-0 · Cited by 21
Oxytocin, Vasopressin and Stress: A Hormetic Perspective
Nazarloo, H. P., Kingsbury, M. A., Lamont, H., Dale, C. V., Nazarloo, P., Davis, J. M., Porges, E. C., Cuffe, S. P., & Carter, C. S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080632 · Cited by 20
“VP, co-released with CRH from parvocellular neurons in the PVN, sustains and amplifies ACTH secretion through V1b receptor activation, particularly under chronic or repeated stressors, thereby contributing to HPA axis sensitization [83].”
InfluentialCopeptin Predicts Mortality in Critically Ill Patients
Krychtiuk, K. A., Honeder, M. C., Lenz, M. W., Maurer, G., Wojta, J., Heinz, G., Huber, K., & Speidl, W. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170436 · Cited by 18
Eckart, A., Hausfater, P., Amin, D., Amin, A., Haubitz, S., Bernard, M., Baumgartner, A., Struja, T., Kutz, A., Christ‐Crain, M., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12764 · Cited by 18
In Sickness and In Health: Interpersonal Risk and Resilience in Cardiovascular Disease
Ruiz, J. M., Hamann, H. A., Coyne, J. C., & Compare, A. (2006) · Springer eBooks · doi:10.1007/978-88-470-0378-1_14 · Cited by 16
Response of Interleukin‐1β in the Magnocellular System to Salt‐Loading
Summy‐Long, J. Y., Hu, S., Pruss, A., Chen, X., & Phillips, T. M. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01490.x · Cited by 17
A complex selection signature at the human AVPR1B gene
Cagliani, R., Fumagalli, M., Pozzoli, U., Riva, S., Cereda, M., Comi, G. P., Pattini, L., Bresolin, N., & Sironi, M. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-123 · Cited by 17
Belity, T., Horowitz, M., Hoffman, J. R., Epstein, Y., Bruchim, Y., Todder, D., & Cohen, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084129 · Cited by 16
Wan, Y., Zhang, Z., Lin, D., Wang, X., Huang, T., Su, J., Zhang, J., Li, J., & Wang, Y. (2022) · Genes · doi:10.3390/genes13101680 · Cited by 17
Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond
Dünser, M. W., & Westphal, M. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282f4571a · Cited by 16
Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats
Nishimura, K., Yoshino, K., Sanada, K., Beppu, H., Akiyama, Y., Nishimura, H., Tanaka, K., Sonoda, S., Ueno, H., Yoshimura, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41714-z · Cited by 15
Co-peptin: Role as a novel biomarker in clinical practice
Dabla, P. K., Dabla, V., & Arora, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.034 · Cited by 15
Serum Copeptin Predicts Severity and Recurrent Stroke in Ischemic Stroke Patients
Tang, W., Wang, X., Li, H., Dong, M., & Ji, X. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9754-5 · Cited by 14
“Vasopressin (AVP) is a potent synergistic factor of corticotropin-releasing hormone as hypothalamic stimulator of the hypothalamo-pituitary-adrenal axis (Volpi et al. 2004).”
V1bvasopressin receptor trafficking and signaling: Role of arrestins, G proteins and Src kinase
Perkovska, S., Méjean, C., Ayoub, M. A., Li, J., Hemery, F., Corbani, M., Laguette, N., Ventura, M. A., Orcel, H., Durroux, T., et al. (2017) · Traffic · doi:10.1111/tra.12535 · Cited by 14
“hypothalamic-pituitary-adrenal (HPA) axis through its involvement in the regulation of adrenocorticotropin (ACTH) release.(1,2) This function highlights the potential of hV1bR as a drug target for stress, anxiety and depression.”
BackgroundEngler, D. (2007) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 15
Jg, G., de Winter, R., Wolterbeek, R., Spinhoven, P., Zitman, F., & Wiegant, V. M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093584 · Cited by 13
Ablation of TrkB signalling in CCK neurons results in hypercortisolism and obesity
Geibel, M., Badurek, S., Horn, J. M., Vatanashevanopakorn, C., Koudelka, J., Wunderlich, C. M., Brönneke, H. S., Wunderlich, F. T., & Minichiello, L. (2014) · Nature Communications · doi:10.1038/ncomms4427 · Cited by 13
Imaging the Hypothalamo-Neurohypophysial System
Bárez‐López, S., Scanlon, L., Murphy, D., & Greenwood, M. P. (2021) · Neuroendocrinology · doi:10.1159/000519233 · Cited by 14
Mechanisms underlying the effects of stress on tumorigenesis and metastasis (Review)
Zhang, Z., Wang, Y., & Li, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4570 · Cited by 13
“Corticotrophinreleasing hormone (CRH) and arginine vasopressin (AVP), released from the hypothalamus, can activate the pituitary gland to release adrenocorticotropic hormone (ACTH), encephalin and endorphin (END), and the adrenal cortex to release ACTH-induced glucocorticoid (GC) (3,27).”
Hu, W., Ni, Y., Ma, L., Hao, H., Chen, L., & Yu, W. (2015) · Europe PMC (PubMed Central) · Cited by 11
Johnson, E. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00038-9 · Cited by 11
McKlveen, J. M., Wilson, J. M., Rubín, R. T., & Rhodes, M. E. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.01.009 · Cited by 9
“Other studies also support the prolongation of AVP secretion in male rats (Aguilera et al., 2008; Volpi et al., 2004), and a shift to more than half of CRH neurons coexpressing AVP (Aguilera, Kiss, Liu, & Kamitakahara, 2007; Aguilera et al., 2008; Chowdrey et al., 1995; de Goeij et al., 1991; Ma,…”
Influentialvan der Valk, E. S., van der Voorn, B., Iyer, A. M., van den Berg, S. V. D., Savas, M., de Rijke, Y. D., van den Akker, E. V. D., Melander, O., & van Rossum, E. V. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0077 · Cited by 5
Das, S., Komnenov, D., Newhouse, L., Rishi, A. K., & Rossi, N. F. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113867 · Cited by 9
Baba, K., Kawasaki, M., Nishimura, H., Suzuki, H., Matsuura, T., Ikeda, N., Fujitani, T., Yamanaka, Y., Tsukamoto, M., Ohnishi, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17477-5 · Cited by 9
Goekoop, J. G., de Winter, R. F. P., Wolterbeek, R., Kempen, G. M. J. V., & Wiegant, V. M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109349839 · Cited by 9
“The second animal model has been induced by chronic stress, and has been found to induce increased expression of the pituitary vasopressin (V1b)-receptor (Volpi et al., 2004).”
BackgroundInfluence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis
Stojiljković, A. S., Čupić, Ž., Maćešić, S., Ivanović-Šašić, A., & Kolar-Anić, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976323 · Cited by 9
Akyıl, F. T., Önür, S. T., Abalı, H., Sökücü, S. N., Özdemir, C., Boyracı, N., Kocaoğlu, A., & Altın, S. (2021) · The Clinical Respiratory Journal · doi:10.1111/crj.13409 · Cited by 8
“Eosinophil >%2 (n, %) 1123 (34) 978 (38) 145 (20) <0.”
Circuits underlying social function and dysfunction
Wang, Z., Yueh, H., Chau, M., Veenstra-VanderWeele, J. M., & O’Reilly, K. C. (2023) · Autism Research · doi:10.1002/aur.2978 · Cited by 9
Serrière-Lanneau, V., Tran, D., Stelly, N., Claret, M., Alonso, G., Tordjmann, T., & Guillon, G. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.04.008 · Cited by 7
Kong, L., Wu, R., Wang, L., Feng, W., Cao, Y., & Tai, F. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.11.017 · Cited by 6
Zhou, Z., Sun, F., Jiang, J., Dou, Z., Lv, Y., Zhang, Z., Zhou, X., Zhao, X., Qin, Y., & Huang, B. (2023) · Journal of Fluorescence · doi:10.1007/s10895-023-03441-7 · Cited by 6
Takeda, T., Takeda, S., & Kakigi, A. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2024.08.002 · Cited by 7
Mornagui, B., Rezg, R., Grissa, A., Duvareille, M., Gharib, C., Kamoun, A., El‐Fazâa, S., & Gharbi, N. (2010) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0026-6 · Cited by 5
“Thus, in addition to the role of AVP on water conservation, it regulates pituitary ACTH secretion by potentiating the stimulatory effects of CRH and upregulating the pituitary AVP receptors, especially V1b subtype (V1bR, V3R), located in the plasma membrane of the pituitary corticotroph and coupled to calcium–phosphol…”
Metadata
- Authors
- Volpi, S., Rabadan-Diehl, C., & Aguilera, G.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Aguilera, Greti
- ORCID
- Volpi, Simona
- Venue
- Stress
- Publisher
- Informa UK Limited
- Published
- 2004-06
- Volume
- 7
- Issue
- 2
- Pages
- 75-83
- ISSN
- 1025-3890 (ISSN-L)
- 1607-8888
- OpenAlex
- W2094450224
- Cited by
- 136
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 10 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 9 · 2012: 3
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Stress (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- vasopressin, V1b receptor, hypothalamic-pituitary-adrenal axis, ACTH secretion, corticotropin-releasing factor, chronic stress, stress adaptation, phospholipase C signaling, mRNA translation regulation, protein kinase C, internal ribosome entry site, 5' untranslated region
- MeSH terms
- Adaptation, Physiological, Animals, Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Stress, Physiological, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review